دورية أكاديمية
أعرض في EDS

The Role of Fenugreek in the Management of Type 2 Diabetes.

التفاصيل البيبلوغرافية
العنوان: The Role of Fenugreek in the Management of Type 2 Diabetes.
المؤلفون: Haxhiraj M; Diabetes Interest Group, The Centre for Health and Life Sciences Research, London Metropolitan University, London N7 8DB, UK., White K; Diabetes Interest Group, The Centre for Health and Life Sciences Research, London Metropolitan University, London N7 8DB, UK., Terry C; Diabetes Interest Group, The Centre for Health and Life Sciences Research, London Metropolitan University, London N7 8DB, UK.
المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 26; Vol. 25 (13). Date of Electronic Publication: 2024 Jun 26.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI, [2000-
مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/drug therapy , Trigonella*/chemistry , Plant Extracts*/therapeutic use , Plant Extracts*/pharmacology, Humans ; Hypoglycemic Agents/therapeutic use ; Hypoglycemic Agents/pharmacology ; Animals ; Gastrointestinal Microbiome/drug effects
مستخلص: The number of people diagnosed with type 2 diabetes is on the increase worldwide. Of growing concern, the prevalence of type 2 diabetes in children and youths is increasing rapidly and mirrors the increasing burden of childhood obesity. There are many risk factors associated with the condition; some are due to lifestyle, but many are beyond our control, such as genetics. There is an urgent need to develop better therapeutics for the prevention and management of this complex condition since current medications often cause unwanted side effects, and poorly managed diabetes can result in the onset of related comorbidities. Naturally derived compounds have gained momentum for preventing and managing several complex conditions, including type 2 diabetes. Here, we provide an update on the benefits and limitations of fenugreek and its components as a therapeutic for type 2 diabetes, including its bioavailability and interaction with the microbiome.
References: Nat Rev Drug Discov. 2021 Mar;20(3):200-216. (PMID: 33510482)
J Allergy Clin Immunol. 2009 Jan;123(1):187-94. (PMID: 18930518)
J Diet Suppl. 2021;18(1):31-43. (PMID: 32081056)
Food Sci Nutr. 2022 Jun 07;10(10):3475-3484. (PMID: 36249963)
Nutr Metab (Lond). 2022 Nov 8;19(1):76. (PMID: 36348361)
J Biol Chem. 2015 Oct 23;290(43):26235-48. (PMID: 26336108)
Food Chem Toxicol. 2017 Dec;110:434-442. (PMID: 28923438)
J Cell Mol Med. 2023 Jul;27(14):1959-1974. (PMID: 37257051)
J Pharm Pharmacol. 2017 Jul;69(7):856-864. (PMID: 28271502)
Int J Mol Sci. 2024 Apr 27;25(9):. (PMID: 38732002)
Metab Syndr Relat Disord. 2016 Mar;14(2):114-20. (PMID: 26835874)
Lancet. 1997 Jul;350 Suppl 1:SI20-3. (PMID: 9250279)
Ayu. 2013 Jan;34(1):109-12. (PMID: 24049415)
J Nephropharmacol. 2015 Jan 01;4(1):27-30. (PMID: 28197471)
Front Biosci (Landmark Ed). 2023 Sep 27;28(9):229. (PMID: 37796709)
Front Endocrinol (Lausanne). 2023 Aug 25;14:1213711. (PMID: 37693358)
Pharmaceuticals (Basel). 2023 Mar 30;16(4):. (PMID: 37111272)
Drug Dev Res. 2023 Dec;84(8):1652-1663. (PMID: 37712494)
Am J Physiol Endocrinol Metab. 2004 Sep;287(3):E463-71. (PMID: 15082420)
Nutr Neurosci. 2018 Oct;21(8):539-545. (PMID: 28504078)
Gut. 2020 Aug;69(8):1510-1519. (PMID: 32409589)
J Diet Suppl. 2018 Jan 2;15(1):98-107. (PMID: 28558255)
Front Nutr. 2020 Jun 02;7:64. (PMID: 32582751)
Diabetes Obes Metab. 2017 Jun;19(6):906-908. (PMID: 28105738)
J Cardiovasc Thorac Res. 2021;13(1):28-36. (PMID: 33815699)
Sci Rep. 2018 Jan 18;8(1):1116. (PMID: 29348618)
Antioxidants (Basel). 2021 Jan 07;10(1):. (PMID: 33430470)
Toxics. 2022 Jun 30;10(7):. (PMID: 35878267)
Eur J Clin Nutr. 1988 Jan;42(1):51-4. (PMID: 3286242)
Prostaglandins Leukot Essent Fatty Acids. 1997 May;56(5):379-84. (PMID: 9175175)
Cardiovasc Diabetol. 2020 Nov 22;19(1):196. (PMID: 33222693)
Biosci Rep. 2022 May 27;42(5):. (PMID: 35475576)
Inflammation. 2020 Aug;43(4):1411-1422. (PMID: 32240451)
Cureus. 2022 Jul 5;14(7):e26597. (PMID: 35936152)
Front Pharmacol. 2022 May 17;13:904643. (PMID: 35656300)
Food Sci Nutr. 2024 Jan 10;12(4):2294-2310. (PMID: 38628211)
Oxid Med Cell Longev. 2018 Jun 5;2018:7634362. (PMID: 29967664)
J Ethnopharmacol. 2020 Jun 28;256:112821. (PMID: 32251758)
Diabetologia. 2023 Jul;66(7):1247-1259. (PMID: 37202507)
Molecules. 2016 Nov 22;21(11):. (PMID: 27879673)
Complement Ther Med. 2020 Mar;49:102315. (PMID: 32147060)
Gene. 2023 Jun 15;869:147383. (PMID: 37001571)
PLoS Med. 2020 May 15;17(5):e1003106. (PMID: 32413037)
Poult Sci. 2022 Jul;101(7):101939. (PMID: 35691048)
J Biosci. 2011 Jun;36(2):383-96. (PMID: 21654091)
J Pharm Biomed Anal. 2018 Sep 10;159:100-112. (PMID: 29980011)
Nutrients. 2019 Aug 08;11(8):. (PMID: 31398884)
Pharmaceutics. 2022 Nov 14;14(11):. (PMID: 36432644)
Sci Rep. 2017 Oct 6;7(1):12770. (PMID: 28986580)
Mol Pharm. 2007 Nov-Dec;4(6):807-18. (PMID: 17999464)
N Engl J Med. 2007 Jun 14;356(24):2457-71. (PMID: 17517853)
Biomolecules. 2021 Dec 14;11(12):. (PMID: 34944521)
Crit Rev Food Sci Nutr. 2023 Nov;63(33):12372-12397. (PMID: 35866515)
Int J Mol Sci. 2021 Apr 22;22(9):. (PMID: 33921991)
Nat Rev Nephrol. 2023 Mar;19(3):168-184. (PMID: 36316388)
J Diabetes Sci Technol. 2014 Sep;8(5):1018-22. (PMID: 25172878)
Drug Res (Stuttg). 2021 Apr;71(4):180-192. (PMID: 33378775)
Biol Sex Differ. 2015 Sep 03;6:14. (PMID: 26339468)
Sci Rep. 2020 Jan 27;10(1):1245. (PMID: 31988303)
Foods. 2020 Aug 21;9(9):. (PMID: 32839396)
Int J Vitam Nutr Res. 2009 Jan;79(1):34-9. (PMID: 19839001)
J Diabetes Metab Disord. 2015 Oct 02;14:74. (PMID: 26436069)
Mol Nutr Food Res. 2018 Mar;62(5):. (PMID: 29210166)
J Clin Endocrinol Metab. 2019 Apr 1;104(4):1211-1220. (PMID: 30418583)
J Diabetes Res. 2021 Oct 7;2021:7796727. (PMID: 34660812)
Food Funct. 2023 Jan 3;14(1):516-524. (PMID: 36520071)
Contraception. 2006 Mar;73(3):301-6. (PMID: 16472574)
Phytother Res. 2009 Nov;23(11):1543-8. (PMID: 19353539)
Nutrients. 2020 Jul 03;12(7):. (PMID: 32635141)
Curr Pharm Des. 2023;29(39):3123-3136. (PMID: 38038009)
Diabetologia. 2017 Sep;60(9):1566-1576. (PMID: 28776081)
Nutr Res. 2012 Jul;32(7):537-41. (PMID: 22901562)
Int J Exp Diabetes Res. 2001;2(2):91-9. (PMID: 12369721)
BMJ. 2020 May 13;369:m1361. (PMID: 32404325)
Nat Rev Endocrinol. 2022 Sep;18(9):525-539. (PMID: 35668219)
Front Pharmacol. 2021 Nov 26;12:777561. (PMID: 34899340)
Int J Mol Sci. 2022 Mar 26;23(7):. (PMID: 35409014)
Life (Basel). 2022 Apr 14;12(4):. (PMID: 35455074)
J Diabetes Investig. 2022 Dec;13(12):2091-2100. (PMID: 36121185)
Mol Nutr Food Res. 2022 Nov;66(22):e2100819. (PMID: 36038526)
N Engl J Med. 2016 Jul 28;375(4):311-22. (PMID: 27295427)
Pharmacotherapy. 2001 Apr;21(4):509-12. (PMID: 11310527)
Clin Sci (Lond). 2012 Mar;122(6):253-70. (PMID: 22117616)
J Funct Foods. 2017 Jun;33:194-201. (PMID: 30416539)
J Ethnopharmacol. 2000 Apr;70(1):65-8. (PMID: 10720790)
Ann Hepatol. 2021 Jul-Aug;23:100255. (PMID: 32950646)
J Food Sci. 2024 Apr;89(4):1835-1864. (PMID: 38407443)
Phytomedicine. 2014 Sep 15;21(10):1154-61. (PMID: 24889525)
Diabetes Care. 2007 Dec;30(12):2993-8. (PMID: 17804680)
Front Nutr. 2015 Feb 12;2:3. (PMID: 25988132)
J Diabetes Res. 2019 Sep 05;2019:8507453. (PMID: 31583253)
Cell Metab. 2014 Dec 2;20(6):953-66. (PMID: 25456737)
Heliyon. 2019 Apr 24;5(4):e01536. (PMID: 31049444)
Eur J Med Chem. 2023 May 5;253:115336. (PMID: 37031528)
Nutrition. 2018 Feb;46:134-142.e3. (PMID: 28993009)
J Gastrointest Cancer. 2022 Sep;53(3):683-686. (PMID: 34472011)
Bioresour Technol. 2022 Jun;354:127196. (PMID: 35460845)
Asia Pac J Clin Nutr. 2007;16 Suppl 1:422-6. (PMID: 17392143)
Br J Nutr. 2007 Mar;97(3):514-21. (PMID: 17313713)
J Nutr Metab. 2014;2014:964873. (PMID: 25276421)
Nestle Nutr Workshop Ser Clin Perform Programme. 2006;11:139-153. (PMID: 16820737)
Medicina (Kaunas). 2023 Jan 27;59(2):. (PMID: 36837450)
Int J Mol Sci. 2023 Sep 12;24(18):. (PMID: 37762302)
EClinicalMedicine. 2021 Jun 14;37:100960. (PMID: 34386746)
Nutr J. 2014 Jan 18;13:7. (PMID: 24438170)
Pharmacogn Mag. 2017 Jan;13(Suppl 1):S135-S141. (PMID: 28479738)
Curr Diab Rep. 2019 Jul 22;19(8):62. (PMID: 31332628)
BMJ Med. 2023 Sep 4;2(1):e000372. (PMID: 37680340)
فهرسة مساهمة: Keywords: 4 hydroxy isoleucine; fenugreek; microbiome; natural compounds; therapeutics; type 2 diabetes
المشرفين على المادة: 0 (Plant Extracts)
0 (Hypoglycemic Agents)
تواريخ الأحداث: Date Created: 20240713 Date Completed: 20240713 Latest Revision: 20240715
رمز التحديث: 20240715
مُعرف محوري في PubMed: PMC11240913
DOI: 10.3390/ijms25136987
PMID: 39000103
قاعدة البيانات: MEDLINE
الوصف
تدمد:1422-0067
DOI:10.3390/ijms25136987